| Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death C Silvestre-Roig, Q Braster, K Wichapong, EY Lee, JM Teulon, ... Nature 569 (7755), 236-240, 2019 | 390 | 2019 |
| Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study J Rosing, S Middeldorp, J Curvers, MCL GDlig, GAF Nicolaes, ... The Lancet 354 (9195), 2036-2040, 1999 | 347 | 1999 |
| Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis KCAA Wildhagen, P García de Frutos, CP Reutelingsperger, R Schrijver, ... Blood, The Journal of the American Society of Hematology 123 (7), 1098-1101, 2014 | 331 | 2014 |
| Factor V and thrombotic disease: description of a janus-faced protein GAF Nicolaes, B Dahlbäck Arteriosclerosis, thrombosis, and vascular biology 22 (4), 530-538, 2002 | 316 | 2002 |
| Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (∗) GAF Nicolaes, G Tans, MCLGD Thomassen, HC Hemker, I Pabinger, ... Journal of Biological Chemistry 270 (36), 21158-21166, 1995 | 314 | 1995 |
| Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C J Rosing, L Hoekema, GAF Nicolaes, MCLGD Thomassen, HC Hemker, ... Journal of Biological Chemistry 270 (46), 27852-27858, 1995 | 311 | 1995 |
| A randomized cross-over study on the effects of levonorgestrel-and desogestrel-containing oral contraceptives on the anticoagulant pathways G Tans, J Curvers, S Middeldorp, MCLGD Thomassen, JCM Meijers, ... Thrombosis and haemostasis 84 (07), 15-21, 2000 | 287 | 2000 |
| Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study S Middeldorp, JCM Meijers, AE van den Ende, A van Enk, BN Bouma, ... Thrombosis and haemostasis 84 (07), 4-8, 2000 | 280 | 2000 |
| Coagulation factor V and thrombophilia: background and mechanisms K Segers, B Dahlbäck, GAF Nicolaes Thrombosis and haemostasis 98 (09), 530-542, 2007 | 257 | 2007 |
| Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance MS Braza, MMT van Leent, M Lameijer, BL Sanchez-Gaytan, RJW Arts, ... Immunity 49 (5), 819-828. e6, 2018 | 223 | 2018 |
| Phenotyping the clotting system HC Hemker, S Béguin Thrombosis and haemostasis 84 (11), 747-751, 2000 | 223 | 2000 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 200 | 2016 |
| Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis C Winter, C Silvestre-Roig, A Ortega-Gomez, P Lemnitzer, H Poelman, ... Cell metabolism 28 (1), 175-182. e5, 2018 | 194 | 2018 |
| Endothelial protein C receptor CT Esmon, J Xu, J Gu, D Qu, Z Laszik, G Ferrell, DJ Stearns-Kurosawa, ... Thrombosis and haemostasis 82 (08), 251-258, 1999 | 185 | 1999 |
| Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis TTP Seijkens, CM van Tiel, PJH Kusters, D Atzler, O Soehnlein, ... Journal of the American College of Cardiology 71 (5), 527-542, 2018 | 175 | 2018 |
| Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis JCM Meijers, S Middeldorp, W Tekelenburg, AE van den Ende, G Tans, ... Thrombosis and haemostasis 84 (07), 9-14, 2000 | 169 | 2000 |
| Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation P Von Hundelshausen, SM Agten, V Eckardt, X Blanchet, MM Schmitt, ... Science translational medicine 9 (384), eaah6650, 2017 | 150 | 2017 |
| Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance A Chatzigeorgiou, T Seijkens, B Zarzycka, D Engel, M Poggi, ... Proceedings of the National Academy of Sciences 111 (7), 2686-2691, 2014 | 147 | 2014 |
| Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene M Gerards, BJC Van Den Bosch, K Danhauser, V Serre, M van Weeghel, ... Brain 134 (1), 210-219, 2011 | 144 | 2011 |
| Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations E Castoldi, JM Brugge, GAF Nicolaes, D Girelli, G Tans, J Rosing Blood 103 (11), 4173-4179, 2004 | 139 | 2004 |
